Den kliniske forekomst af neutraliserende faktorer hos patienter, der fik ViraferonPeg 0, 5 mikrogram/ kg er 1, 1%.
The clinical incidence of neutralising factors in patients who received ViraferonPeg 0.5 micrograms/kg is 1.1%.